Latest Regulatory Clearance News

Control Bionics has closed its Share Purchase Plan, raising $256,500 and pushing total capital raised to $9.75 million, pending shareholder approval for the final tranche.

Solstice Minerals has delivered a standout quarter at its Nanadie Copper-Gold Project, extending mineralisation well beyond the current resource boundary with a massive 629m drill intercept. Backed by a strong $45 million cash position, the company is poised for further resource growth and exploration across its Eastern Goldfields assets.

AFT Pharmaceuticals has received tentative US FDA approval for its Scomara cream to treat Facial Angiofibromas in Tuberous Sclerosis, but US commercialisation is postponed until 2029 due to orphan drug exclusivity. The approval bolsters regulatory prospects in other key markets where AFT anticipates competitive advantages.

PainChek appoints seasoned US medtech executive Karen Holzberger as CEO to spearhead growth following FDA clearance and major US contracts.

EQT’s controlled entity has upped its non-binding offer for Perpetual to A$22.07 per share, a 2% premium on its initial bid. The proposal hinges on Perpetual’s Wealth Management sale and other conditions, with no certainty of a deal.

Orthocell Ltd delivered a standout FY26 with 44% revenue growth to A$13.2 million, powered by accelerating US sales of its nerve repair product Remplir and a robust cash position supporting further expansion.

Genesis Minerals and Vault Minerals have agreed to merge, creating a top-3 Australian gold producer with a pro-forma market cap of about A$12.66 billion and annual production of 600-700koz.

Count Limited has received Australian Competition and Consumer Commission clearance for its Oracle Group acquisition and locked in a $116.6 million debt facility with Commonwealth Bank to fund the deal and support growth.

Toi Foundation has reopened its community consultation on the proposed sale of TSB Bank shares to Heartland Group Holdings due to a procedural error, pushing the trustee decision to August and delaying the merger timeline.

Qube Holdings' acquisition by Rubik Australia is now legally effective following Supreme Court approval, with trading suspension imminent. The company has declared a fully franked special dividend of $0.3465 per share, payable mid-July, ahead of the scheme implementation in August.

Tyranna Resources is divesting its Namibe Lithium and Caesium Project in Angola to Sinomine Resource for US$1.44 million, redirecting capital to its newly acquired Chinguar Gold Project.

Austral Resources Australia Ltd has tabled a non-binding proposal to acquire Hammer Metals Ltd at A$0.087 per share, outbidding Larvotto Resources and aiming to bolster its Rocklands copper operations with a substantial new feed source.